4.7 Article

Aberrant Gene Methylation Is a Biomarker for the Detection of Cancer Cells in Peritoneal Wash Samples from Advanced Gastric Cancer Patients

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Aberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancer

Masatsugu Hiraki et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2010)

Article Gastroenterology & Hepatology

Sensitive and Specific Detection of Early Gastric Cancer with DNA Methylation Analysis of Gastric Washes

Yoshiyuki Watanabe et al.

GASTROENTEROLOGY (2009)

Article Oncology

Analysis of Fecal DNA Methylation to Detect Gastrointestinal Neoplasia

Takeshi Nagasaka et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)

Article Gastroenterology & Hepatology

Methylation of PTCH1a gene in a subset of gastric cancers

Peng Du et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2009)

Article Cell Biology

CHD5 is down-regulated through promoter hypermethylation in gastric cancer

Xian Wang et al.

JOURNAL OF BIOMEDICAL SCIENCE (2009)

Article Medicine, Research & Experimental

DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis

Gyeong Hoon Kang et al.

LABORATORY INVESTIGATION (2008)

Article Oncology

Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients

Manabu Yamamoto et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)

Article Oncology

Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion

Hideki Katayama et al.

INTERNATIONAL JOURNAL OF CANCER (2007)

Article Biochemistry & Molecular Biology

MethyLight: a high-throughput assay to measure DNA methylation

Cindy A. Eads et al.

NUCLEIC ACIDS RESEARCH (2000)

Article Surgery

Recurrence following curative resection for gastric carcinoma

CH Yoo et al.

BRITISH JOURNAL OF SURGERY (2000)